AUK-31916-65240
4 vaccinations
1 coded response
38 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 890 / NV
- Registered
- 2021-01-12
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-12
Registered in v-safe
-
2021-01-12
Dose 1 — Pfizer-BioNTech
- 2021-01-12
- 2021-01-13
-
2021-01-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, Nausea, Abdominal painAdult check-in
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-26
-
2021-02-02
Dose 2 — Pfizer-BioNTech
- 2021-02-02
-
2021-02-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-02-04
- 2021-02-06
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-02-08
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-16
- 2021-05-04
- 2021-08-03
-
2021-11-27
Dose 3 — Pfizer-BioNTech
- 2022-02-02
- 2022-05-30
- 2022-11-29
-
2022-12-18
Dose 4 — Pfizer-BioNTech
- 2022-12-21
- 2022-12-22
- 2022-12-23
- 2022-12-24
- 2022-12-25
- 2023-01-01
- 2023-01-08
- 2023-01-15
- 2023-01-22
-
2023-01-29
Survey response — day 42, dose 4MedDRA: Abortion spontaneous, Heavy menstrual bleeding, Office visit — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11
-
2023-01-29
Report sent to call center — day 42, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2023-01-30
Call successfulParticipant prefers to complete VAERS report online
- 2023-03-19
- 2023-06-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-12 | Pfizer-BioNTech | |
| 2 | 2021-02-02 | Pfizer-BioNTech | |
| 3 | 2021-11-27 | Pfizer-BioNTech | No |
| 4 | 2022-12-18 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-01-29 | Successful 2023-01-30 |
Participant prefers to complete VAERS report online |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release